Major technological advance is changing treatment for patients requiring dialysis for kidney failure
Surgical oncologist Ajay Jain, M.D., has established his practice with the Stephenson Cancer Center at OU Medicine.
People with prediabetes or other risk factors for type 2 diabetes can reduce their risk of the disease by participating in the Harold Hamm Diabetes Center’s PreventT2 program.
OU Medicine neurosurgeons are using a new medical device to prevent aneurysm rupture and recurrence
OU Medicine earned membership in the national HLHS Consortium.
The Stephenson Cancer Center welcomes a new tobacco regulatory scientist, Amy Cohn, Ph.D., to join a growing team of researchers dedicated to reducing the burden of tobacco-related diseases and deaths in Oklahoma.
Dr Ralf Janknecht awarded a five-year, $1.78 million grant from the National Cancer Institute to further evaluate a particular molecule’s potential in reducing cancer metastasis.
For smokers who are trying to quit, what if a smartphone app could predict when they are most likely to relapse and light a cigarette? Such technology has been created at the Oklahoma Tobacco Research Center.